Alessandra Boletta - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Alessandra Boletta

Showing results (61-70 of 63) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 63 results.

Blood|April 29, 2025

The mitochondrial protease ClpP is a metabolic vulnerability and an immunogenic trigger against multiple myelomaTommaso Perini, Paola Zordan, Rossella Del Pizzo, et al.

Cell Reports|April 7, 2021

The anti-inflammatory cytokine interleukin-37 is an inhibitor of trained immunityGiulio Cavalli, Isak W Tengesdal, Mark Gresnigt, et al.

Blood|June 2, 2021

Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester diseaseRaffaella Molteni, Riccardo Biavasco, Davide Stefanoni, et al.

Pageof 7

Search research articles

Showing results (61-70 of 63) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 63 results.

Blood|April 29, 2025

The mitochondrial protease ClpP is a metabolic vulnerability and an immunogenic trigger against multiple myelomaTommaso Perini, Paola Zordan, Rossella Del Pizzo, et al.

Cell Reports|April 7, 2021

The anti-inflammatory cytokine interleukin-37 is an inhibitor of trained immunityGiulio Cavalli, Isak W Tengesdal, Mark Gresnigt, et al.

Blood|June 2, 2021

Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester diseaseRaffaella Molteni, Riccardo Biavasco, Davide Stefanoni, et al.

Pageof 7